Virginia Retirement Systems’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.7M | Sell |
|
|||||
2025
Q1 | $46.4M | Buy |
|
|||||
2023
Q3 | $67.6M | Buy |
|
|||||
2023
Q2 | $13.6M | Sell |
|
|||||
2023
Q1 | $18.3M | Buy |
|
|||||
2022
Q4 | $21.1M | Sell |
|
|||||
2022
Q3 | $19.4M | Buy |
|
|||||
2021
Q2 | – | Sell |
|
|||||
2021
Q1 | $263K | Buy |
|
|||||
2020
Q3 | – | Sell |
|
|||||
2020
Q2 | $1.79M | Buy |
|
|||||
2020
Q1 | $502K | Sell |
|
|||||
2019
Q4 | $2.78M | Buy |
|
|||||
2019
Q3 | $1.53M | Buy |
|
|||||
2019
Q2 | $1.42M | Buy |
|
|||||
2019
Q1 | $784K | Buy |
|
|||||
2018
Q4 | $443K | Hold |
|
|||||
2018
Q3 | $762K | Hold |
|
|||||
2018
Q2 | $609K | Buy |
|